Brad Margus has been tapped to co-chair the oversight board for the Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a new, innovative program at the National Institutes of Health.

NeuroNEXT, will provide a robust, standardized, and expert network of 25 clinical centers across the USA to more quickly test treatments for adults and children with neurological disorders. It promises to alleviate some of the current bottlenecks in the development of new drugs for neurological disorders and could be useful to test promising therapies for A-T.

Oops! We could not locate your form.

Related News

Feb 25 @ 1:04 am

Looking Forward to Research Advances in 2024

Dear Friends, As 2023 is wrapping up, we want to thank all of you who support the A-T…

more
Feb 25 @ 1:04 am

A-T Biomarker Development Initiative Now Recruiting

On December 18, the A-T Children’s Project sent out the below email to A-T parents in the United…

more
Feb 25 @ 1:04 am

A-T Caregiver Weekend 2024 Announced

On December 15, the A-T Children’s Project sent the below email to parents inviting them to join us…

more
Feb 25 @ 1:04 am

Giving Tuesday Update 2023

It’s Giving Tuesday, and anonymous donors have joined together to match the first $60,000 in donations we receive!

more